Hypertension
Conditions
Interventions
Intervention group:According to the dosage requirements of this product
The route of administration for this product is oral
Dosage frequency and dose:
1. Blood pressure level: SBP 140~149 mmHg and/or DBP 90~99 mmHg
Dosage (intervention phase): 1 capsule in the morning and evening
Duration of use (intervention phase): 7±5 days
Dosage (after blood pressure stabilization, dose reduction phase): 1 capsule every 5 days
Duration of use (dose reduction phase): 14 days.
2. Blood pressure level: SBP 150~159 mmHg and/or DBP 90~99/=99 mmHg
Dosage (intervention phase): 2 capsules in the morning and evening
Duration of use (intervention phase):10±5 days
Dosage (after blood pressure stabilization, dose reduction phase):1 capsule every3days
Durationofuse(dosereductionphase) :14days.
Sponsors
Lanzhou University First Hospital; School of Basic Medical Sciences, Lanzhou University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Age: 18 years old and above; (2) Fully understand and voluntarily sign the informed consent form; (3) Patients diagnosed with primary hypertension and mild hypertension, including ? newly diagnosed hypertensive patients who have not received any antihypertensive medications, or ? patients diagnosed with hypertension who have a history of taking antihypertensive medications. Must meet all the above criteria to be included.
Exclusion criteria
Exclusion criteria: (1) Patients with allergic reactions to this medication; (2) Liver dysfunction; (3) Impaired liver function; (4) Pregnant and lactating women; (5) Participated in other clinical trials within the past 3 months; (6) Situations deemed unsuitable for participation in this study by the researchers. Any of the above criteria, do not include.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure (SBP);Diastolic blood pressure (DBP); | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulse and heart rate;Adverse events;Heart rate; | — |
Countries
China
Contacts
Public ContactJunqiang Niu; Wenru Shang
Lanzhou University First Hospital; Lanzhou University
Outcome results
None listed